Incidental detection of Candida auris in an orthopedic patient at a Danish university level-II trauma center

Satoh K, Makimura K, Hasumi Y, Nishiyama Y, Uchida K, Yamaguchi H. Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital. Microbiol Immunol 2009; 53: 41-4. doi: 10.1111/j.1348-0421.2008.00083.x DOI: https://doi.org/10.1111/j.1348-0421.2008.00083.x

Rutala W A, Kanamori H, Gergen M F, Sickbert-Bennett E E, Weber D J. Susceptibility of Candida auris and Candida albicans to 21 germicides used in healthcare facilities. Infect Control Hosp Epidemiol 2019; 40(3): 380-2. doi: 10.1017/ice.2019.1 DOI: https://doi.org/10.1017/ice.2019.1

Screening Recommendations for Healthcare Facilities | Candida auris (C. auris) | CDC [cited 2025 April 9]. Available from: https://www.cdc.gov/candida-auris/hcp/screening-hcp/index.html#cdc_generic_section_3-who-and-when-to-screen

National infection control guidelines (NIR). Additional precautions for infections and carrier status in the healthcare sector, 2019 [cited 2025 Apr 9]. Available from: https://hygiejne.ssi.dk/NIRsupplerende

Piedrahita C T, Cadnum J L, Jencson A L, Shaikh A A, Ghannoum M A, Donskey C J. Environmental surfaces in healthcare facilities are a potential source for transmission of Candida auris and other Candida species. Infect Control Hosp Epidemiol 2017; 38(9): 1107-9. doi: 10.1017/ice.2017.127 DOI: https://doi.org/10.1017/ice.2017.127

European Centre for Disease Prevention and Control. Candida auris in healthcare settings – Europe – first update, 23 April 2018. Stockholm: ECDC; 2018 [cited 2025 April 9]. Available from: https://www.ecdc.europa.eu/sites/default/files/documents/RRA-Candida-auris-European-Union-countries.pdf

World Health Organization. WHO fungal priority pathogens list to guide research, development and public health action. Geneva: WHO; 2022; 1: 1-48. Available from: https://www.who.int/publications/i/item/9789240060241

Eix E F, Nett J E. Candida auris: epidemiology and antifungal strategy. Annu Rev Med 2025; 76: 57-67. doi: 10.1146/annurev-med-061523-021233 DOI: https://doi.org/10.1146/annurev-med-061523-021233

Taori S K, Khonyongwa K, Hayden I, Athukorala G D A, Letters A, Fife A, et al. Candida auris outbreak: mortality, interventions and cost of sustaining control. J Infect 2019; 79(6): 601-11. doi: 10.1016/j.jinf.2019.09.007 DOI: https://doi.org/10.1016/j.jinf.2019.09.007

Bhargava A, Klamer K, Sharma M, Ortiz D, Saravolatz L. Candida auris: a continuing threat. Microorganisms 2025; 13(3): 652. doi: 10.3390/microorganisms13030652. DOI: https://doi.org/10.3390/microorganisms13030652

Fasciana T, Cortegiani A, Ippolito M, Giarratano A, Di Quattro O, Lipari D, et al. Candida auris: an overview of how to screen, detect, test and control this emerging pathogen. Antibiotics 2020; 9(11): 1-14.doi: 10.3390/antibiotics9110778 DOI: https://doi.org/10.3390/antibiotics9110778

Infection Control Guidance: Candida auris | Candida auris (C. auris) | CDC [cited 2025 Apr 9]. Available from: https://www.cdc.gov/candida-auris/hcp/infection-control/index.html

Jolivet S, Fournier S, Bigot J, Galal L, Le Roux E, Bonnet M, et al. Value of qPCR in the screening strategy for Candida auris. Med Mycol 2025; 63(5): myaf041 doi: 10.1093/mmy/myaf041. DOI: https://doi.org/10.1093/mmy/myaf041

Kenters N, Kiernan M, Chowdhary A, Denning D W, Pemán J, Saris K, et al. Control of Candida auris in healthcare institutions: outcome of an International Society for Antimicrobial Chemotherapy expert meeting. Int J Antimicrob Agents 2019; 54(4): 400-6. doi: 10.1016/j.ijantimicag.2019.08.013. DOI: https://doi.org/10.1016/j.ijantimicag.2019.08.013

Kurutz A, Innes G K, Sherman A, Kelley L, Stephens K, Kopp P, et al. Candida auris containment responses in health care facilities that provide hemodialysis services – New Jersey, North Carolina, South Carolina, and Tennessee, 2020–2023. MMWR Morb Mortal Wkly Rep 2025; 74(25): 415-21. doi: 10.15585/mmwr.mm7425a1. DOI: https://doi.org/10.15585/mmwr.mm7425a1

Eyre D W, Sheppard A E, Madder H, Moir I, Moroney R, Quan T P, et al. A Candida auris outbreak and its control in an intensive care setting. N Engl J Med 2018; 379(14): 1322-31. doi: 10.1056/NEJMoa1714373. DOI: https://doi.org/10.1056/NEJMoa1714373

Cheng A, Brody K, Ehni J, Gallate Z, Lorin S, Camins B, et al. Analysis of an expanded admission screening protocol for Candida auris at a New York City hospital. Am J Infect Control 2025; 53(1): 70-4. doi: 10.1016/j.ajic.2024.08.027. DOI: https://doi.org/10.1016/j.ajic.2024.08.027

Danielsen A S, Ødeskaug L E, Raastad R, Kjerulf A, Andersen A M, Tornes R A, et al. Key factors to consider for Candida auris screening in healthcare settings: a systematic review. Mycoses 2025; 68(3): e70043. doi: 10.1111/myc.70043. DOI: https://doi.org/10.1111/myc.70043

Voorn M G, Kelley A M, Chaggar G K, Li X, Teska P J, Oliver H F. Contact time and disinfectant formulation significantly impact the efficacies of disinfectant towelettes against Candida auris on hard, non-porous surfaces. Sci Rep 2023; 13(1): 5849. doi: 10.1038/s41598-023-32876-y. DOI: https://doi.org/10.1038/s41598-023-32876-y

Omardien S, Teska P. Skin and hard surface disinfection against Candida auris: what we know today. Front Med (Lausanne) 2024; 11. doi: 10.3389/fmed.2024.1312929. DOI: https://doi.org/10.3389/fmed.2024.1312929

Lionakis M S, Chowdhary A. Candida auris infections. N Engl J Med 2024; 391(20): 1924-35. doi: 10.1056/NEJMra2402635. DOI: https://doi.org/10.1056/NEJMra2402635

Tsay S, Kallen A, Jackson B R, Chiller T M, Vallabhaneni S. Approach to the investigation and management of patients with Candida auris, an emerging multidrug-resistant yeast. Clin Infect Dis 2018; 66(2): 306-11. doi: 10.1093/cid/cix744. DOI: https://doi.org/10.1093/cid/cix744